SEATTLE, WASHINGTON / ACCESS Newswire / June 20, 2025 / Aptevo Therapeutics Inc. (Nasdaq:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, today announced the closing of its previously announced offering of (i) 2,465,000 shares of its common stock or pre-funded warrants in lieu thereof and (ii) warrants to purchase up to an aggregate of 12,325,000 shares of its common stock (the "Common Warrants") at a purchase price of $3.25 per share and associated Common Warrants in a registered direct offering priced at-the-market under Nasdaq rules. Each share of common stock is being offered together with five Common Warrants, each to purchase one share of common stock.
FRIENDSWOOD, Texas, June 19, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that on June 14, 2025, the Compensation Committee of its Board of Directors granted restricted stock units (RSUs) to 66 employees covering an aggregate of 135,978 shares of common stock as an inducement material to their entering into employment with Castle Biosciences. The RSUs were granted pursuant to the Company's 2022 Inducement Plan in accordance with Nasdaq Listing Rule 5635(c)(4).
On Wednesday morning, the cancer diagnostics biotech firm Caris Life Sciences rang Nasdaq's opening bell in New York, marking the company's awaited initial public offering.
Financial - Data & Stock Exchanges Industry | Financial Services Sector | Ms. Adena T. Friedman CEO | NASDAQ (NGS) Exchange | 631103108 Cusip |
US Country | 9,377 Employees | 14 Mar 2025 Last Dividend | 29 Aug 2022 Last Split | 1 Jul 2002 IPO Date |
Nasdaq, Inc. is a global technology company that serves capital markets and a variety of other industries, marking its presence worldwide. The company operates across three primary segments: Capital Access Platforms, Financial Technology, and Market Services. Initially known as The NASDAQ OMX Group, Inc., the company underwent a name change to Nasdaq, Inc. in September 2015, continuing its legacy since its inception in 1971. With its headquarters located in New York, New York, Nasdaq, Inc. has been at the forefront of providing innovative financial products, technology solutions, and market services designed to enhance the efficiency and transparency of the capital markets.
This segment is integral to Nasdaq's offerings, focusing on the distribution of historical and real-time market data. It encompasses developing and licensing Nasdaq-branded indices and financial products, providing investor relations intelligence, governance solutions, ESG solutions, insights, and workflow solutions. It also includes the operation of listing platforms, making it a crucial component for enterprises seeking capital market access and compliance.
Nasdaq's Financial Technology segment presents a range of solutions aimed at combating financial fraud and enhancing regulatory compliance, including:
The Market Platforms segment of Nasdaq, Inc. provides a variety of trading and clearing services across multiple asset classes. These include: